Dima Shulkin: Emerging Biomarkers for Early Prediction of Sepsis-Induced Shock
Dima Shulkin, Co-Founder and CTO at RobotDreams GmbH, shared a post on LinkedIn about a recent article by Jia Li et al, published in Frontiers in Pharmacology, adding:
“Could a blood test warn doctors hours before a sepsis patient takes a dangerous turn?
A 2026 review in Frontiers in Pharmacology by Li and colleagues explores that hope.
Sepsis is the body’s runaway reaction to infection.
When it goes far enough, blood pressure crashes and organs fail.
In some intensive care units, more than 4 in 10 of these patients die.
The authors look at tiny ‘warning signals’ in the blood that rise before the usual symptoms.
In one cited study of 142 patients, a signal called IL-6 correctly flagged the high-risk patients about 80 percent of the time.
Most signals still need testing before doctors can fully trust them.”
Title: Early biomarkers for predicting sepsis-induced shock: insights from inflammatory pathways and immune response
Authors: Jia Li, Qiufang Zhao, Haiyun Gao, Hongjun Wang, Cong Guo, Xiaoling Feng
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 17:27John Strouse: Building Standards for Whole-Person Sickle Cell Care Through Collaboration
-
Oct 17, 2026, 17:20Jean-Jacques Kiladjian: Exploring the Future of Polycythemia Vera Treatment at MPN Horizons 2026
-
Oct 17, 2026, 17:10Habib Bennaceur: Strengthening Collaboration in Haemophilia, Sickle Cell Disease and Thalassaemia in India
-
Oct 17, 2026, 16:58Danny Hsu: Building Connections at the AUSNBled Collaborative Dinner in Auckland
-
Oct 17, 2026, 16:48Kalyan Roy: Enhancing Patient Experience Through Learning and Collaboration
-
Oct 17, 2026, 16:43Wilfried Dinh: Antiplatelet Therapy in 2026: Duration is Becoming a Dynamic Decision
-
Oct 17, 2026, 16:37Ian Setchfield: Dr. Evans Presents on Safe Anticoagulation Prescribing at East Kent Hospitals
-
Oct 17, 2026, 16:33Lewis Thomas: Connecting Through Shared Experiences at ASCAT 2026
-
Oct 17, 2026, 16:29Nilesh Jethwa: Yasmin Adverse Event Reports Exceed 23,000 Over Two-Year Period